Back to search
Type 2 Idiopathic Macular Telangiectasia
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Type 2 Idiopathic Macular Telangiectasia trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Type 2 Idiopathic Macular Telangiectasia trials you may qualify forThis study is conducted to evaluate the safety of THR-317 when administered intravitreally and to assess the compound's efficacy in reducing central subfield th…
Macular telangiectasia type 2 ("MacTel Type 2") is an uncommon eye disorder that results in slow vision loss beginning in middle age. The macula is the central…
This study is a phase 1, open label, non-randomized, multi-center, pilot study to evaluate the safety and tolerability of NT-501 implants in 5-7 study participa…
The purpose of this study is to investigate if a new drug called ranibizumab is effective to treat a rare bilateral disease of the macula: type 2 idiopathic mac…